References
- Järemo P, Milovanovic M, Nilsson S, Buller C, Post C, Winblad B. Alzheimer's disease is characterized by more low density erythrocytes with increased volume and enhanced β-amyloid X-40 content. J Int Med 2011;270:489–92.
- Gardella JE, Ghiso J, Gorgone GA, Marratta D, Kaplan AP, Frangione B, Gorevic PD. Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA. Biochem Biophys Res Commun 1990;173:1292–98.
- Chen M, Inestrosa NC, Ross GS, Fernandez HL. Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 1995;213:96–103.
- Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E Currie J, Ames D, Weidemann A, Fischer P. The amyloid precursor protein of Alzheimer's disease is released by human platelets. J Biol Chem 1990;265:15977–83.
- Vignini A, Sartini D, Morganti S, Nanetti L, Luzzi S, Provinciali L, Mazzanti L, Emanuelli M. Platelet amyloid precursor protein isoform expression in Alzheimer's disease: evidence for peripheral marker. Int J Immunopathol Pharmacol 2011;24:529–34.
- Laske C, Leyhe T, Stransky E, Eschweiler GW, Bueltmann A, Langer H, Stellos K, Gawaz M. Association of platelet-derived soluble glycoprotein VI in plasma with Alzheimer's disease. J Psychiatr Res 2008;42:746–51.
- Laske C, Stransky E, Leyhe T, Eschweiler GW, Schott K, Langer H, Gawaz M. Decreased brain-derived neurotrophic factor (BDNF)- and beta-thromboglobulin (beta-TG)- blood levels in Alzheimer's disease. Thromb Haemost 2006;96: 102–03.
- Ciabattoni G, Porreca E, Di Febbo C, Di Iorio A, Paganelli R, Bucciarelli T, Pescara L, Del Re L, Giusti C, Falco A, Sau A, Patrono C, Davì G. Determinants of platelet activation in Alzheimer's disease. Neurobiol Aging 2007;28: 336–42.
- Stellos K, Panagiota V, Kögel A, Leyhe T, Gawaz M, Laske C. Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients. J Cereb Blood Flow Metab 2010;30:1817–20.
- Järemo P, Milovanovic M, Nilsson S, Buller C, Winblad B. Platelet heterogeneity and Alzheimer's disease: low density platelets populations demonstrate low in vivo activity. Platelets 2012;23:116–20.
- Prodan CI, Ross ED, Vincent AS, Dale GL. Coated-platelets correlate with disease progression in Alzheimer disease. J Neurol 2007;254:548–49.
- Prodan CI, Ross ED, Stoner JA, Cowan LD, Vincent AS, Dale GL. Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology 2011;76:247–52.
- McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001;86:746–56.
- Théorêt JF, Yacoub D, Hachem A, Gillis MA, Merhi Y. P- selectin ligation induces platelet activation and enhances microaggregate and thrombus formation. Thromb Res 2011; 128:243–50.
- Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848–51.
- Fijnheer R, Frijns CJ, Korteweg J, Rommes H, Peters JH, Sixma JJ, Nieuwenhuis HK. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997;77: 1081–85.
- Milovanovic M, Fransson E, Hallert C, Järemo P. Atrial fibrillation and platelet reactivity. Internat J Cardiol 2010; 145:357–58.